31
Patterson Gregory M L, Moore Richard E, Carmeli Shmuel, Smith Charles D, Kimura Lucille H: New scytophycin compounds, compositions and methods for their production and use. University Of Hawaii, WESEMAN James C, April 15, 1993: WO/1993/006825

Novel scytophycin compounds and compositions are disclosed, along with methods of making and using the new compounds. Methods for preparing the new scytophycin compounds from new strains of the blue-green algae $i(Scytonema ocellatum), $i(Scytonema burmanicum) and purified cultures of the algae are ...


32
Miller Jeffrey E: Methods and compositions for cdna synthesis. Miller Jeffrey E, WESEMAN James C, June 23, 1994: WO/1994/013689

Methods and compositions for synthesizing cDNA $i(in vivo) are disclosed, wherein a synthetic polynucleotide molecule which anneals $i(in vivo) to an RNA template molecule is utilized as a primer for reverse transcriptase $i(in vivo).


33
Redenbaugh M Keith, Reyes Zoila: Coating hydrogel capsules. Plant Genetics, WESEMAN James C, July 18, 1985: WO/1985/002972

Methods and materials for coating hydrogel capsules to control the migration of solutes or solvents between the capsule and the environment. The membranes may be of a single compound or various compounds which provide control over the migration of distinct elements.


34
Johnson Lorin K, Atlas Steven A, Mccarthy Brian J, Laragh John H, Lewicki John A: Novel atrial natriuretic/vasodilator polypeptides. Biotechnology Research Partners, Johnson Lorin K, Atlas Steven A, Mccarthy Brian J, Laragh John H, Lewicki John A, WESEMAN James C, November 7, 1985: WO/1985/004870

Methods and compositions for inducing natriuresis, diuresis and vasodilatation in mammalian hosts by administering atrial natriuretic/vasodilator polypeptides to said host. Also provided are methods for producing such polypeptides, and antibodies which are capable of recognizing and specifically bin ...


35
Lewicki John A, Scarborough Robert M Jr, Johnson Lorin K: Analogs of atrial natriuretic peptides. Biotechnology Research Associates Jv, WESEMAN James C, May 7, 1987: WO/1987/002674

Compounds and compositions comprising synthetic analogs of Atrial Natriuretic Peptides, together with methods for their production and use as natriuretics, diuretics and/or vasodilators, or as intermediates for or modulators of such useful compounds or of native Atrial Natriuretic Peptides.


36
Stuart David A, Strickland Steven G: Methods and media for enhanced somatic embryogenesis. Plant Genetics, WESEMAN James C, May 7, 1987: WO/1987/002701

Methods and media to improve the quantity and quality of the embryos obtained by induction of somatic plant tissue. Media provide for the addition of an amount of selected amino acids sufficient to increase the number of somatic embryos generated. The invention further provides for such media includ ...


37
Asato Alfred E, Liu Robert S H: Azulenic retinoid compounds, compositions and methods. University Of Hawaii, WESEMAN James C, December 10, 1992: WO/1992/021643

Novel azulenic retinoid compounds and therapeutic compositions are disclosed, along with method for their production and use as anti-cancer and cancer-prevention agents. The compositions of the present invention will also find use in treating dermatological disorders such as acne and psoriasis, as w ...


38
Mullarkey Michael F: Methods and compositions for treating allergic reactions. Mullarkey Michael F, WESEMAN James C, April 29, 1993: WO/1993/007863

Methods and compositions for treating allergic reactions, including cutaneous, ocular, nasal and bronchial allergic disease, are disclosed. Interleukin-1 and Tumor Necrosis Factor receptors, and analogues thereof, are employed which bind the respective effector competitively and thereby suppress all ...


39
Rath Matthias W, Pauling Linus C: (a) Binding inhibitors. Therapy 2000, WESEMAN James C, December 26, 1991: WO/1991/019488

A method and pharmaceutical composition are provided for the prevention and treatment of cardiovascular disease, particularly cardiovascular disease in the context of diabetic angiopathy, by-pass surgery, organ transplantation, and hemodialysis, by administering ascorbate and substances that inhibit ...


40
Wang Jing, Ramnarayan Kalyanaraman, Rideout Darryl, Mong Seymour, Zhu Hengyi, Niemeyer Christina, Brady Thomas P: Methods and compositions for treating inflammatory diseases utilizing inhibitors of tumor necrosis factor activity. Structural Bioinformatics, WESEMAN James C, June 8, 2000: WO/2000/032598

Methods and compositions that act as specific inhibitors of TFN-dependent NF-$g(k)B activation signaled by certain members of the TFN receptor superfamily for the prophylaxis and treatment of inflammatory diseases.